PerkinElmer Board Declares Quarterly Dividend
25 Avril 2023 - 10:05PM
Business Wire
The Board of Directors of PerkinElmer, Inc. (NYSE: PKI) today
declared a regular quarterly dividend of $0.07 per share of common
stock. This dividend is payable on August 11, 2023 to all
shareholders of record at the close of business on July 21,
2023.
About The PerkinElmer Life Sciences and Diagnostics
Company
The PerkinElmer Life Sciences and Diagnostics company – which is
to be renamed during the second quarter of 2023 – provides
end-to-end solutions that help scientists, researchers and
clinicians better diagnose disease and discover new and more
personalized drugs. The Company reported revenues of approximately
$3.3 billion in 2022, serves customers in 190 countries, and is a
component of the S&P 500 index. Additional information is
available at www.perkinelmer.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230425005745/en/
Investor Relations: Steve Willoughby (781) 663-5677
steve.willoughby@perkinelmer.com
Media Relations: Chet Murray (781) 663-5719
chet.murray@perkinelmer.com
PerkinElmer (NYSE:PKI)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
PerkinElmer (NYSE:PKI)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024
